NPS Pharmaceuticals, Inc., President and Chief Executive Officer Francois Nader, MD, has been President, Chief Executive Officer and a member of the Board of Directors of NPS Pharmaceuticals since 2008. During his tenure, Dr. Nader transformed NPS into a leading global biotechnology company focused on pioneering and delivering innovative therapies that transform the lives of… Read the full article
Celgene Corporation, Former Chairman Dr. Barer is the Former Chairman and CEO of Celgene. He was Chairman and Chief Executive Officer from May 1, 2006 until June 16, 2010 and Executive Chairman subsequently until January 1, 2011 when he transitioned to his current position. Previously he was appointed President in 1993 and Chief Operating Officer… Read the full article
BioNJ, President and CEO Debbie Hart, President and CEO of BioNJ, worked alongside New Jersey’s biotechnology industry leaders to establish BioNJ in 1994. BioNJ seeks to promote a business and public policy environment in New Jersey, Washington,D.C. and beyond that advances the growth and prosperity of New Jersey’s biotechnology companies.
Soligenix, Inc., President and Chief Executive Officer Christopher J. Schaber, PhD has over 25 years experience in the pharmaceutical and biotechnology industry. Dr. Schaber has been Soligenix’s President and Chief Executive Officer and a director since August 2006.
Drais Pharmaceuticals Inc., President and Chief Executive Officer Dr. Tempel is President, Chief Executive Officer and co-founder of Drais Pharmaceuticals Inc. Drais is a venture-capital supported clinical drug development company, based in Bridgewater, New Jersey.
Elusys Therapeutics, Inc., President and Chief Executive Officer Elizabeth has 25 years of experience in the biopharmaceutical industry and has held senior positions in general management, business development, marketing and operations. She joined Elusys in 2002 as Vice President of Business Development and since then was promoted to Sr. Vice President of Operations and then… Read the full article